Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019 [Phase 3]
Long-term extension study in multiple sclerosis participants completed following a prior trial; terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) [Phase 3]
Phase 3 extension study in pediatric relapsing-remitting multiple sclerosis completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Testosterone Treatment for Multiple Sclerosis [Phase 1, Phase 2]
Clinical trial update on testosterone treatment for multiple sclerosis (Phase 1/2) completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants Who Have Participated in Cladribine Clinical Trials
A long-term safety registry observational study following multiple sclerosis participants who previously took cladribine, with completed sta…
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis [Phase 3]
Phase 3 clinical trial updating results for IPX056 in established spasticity due to multiple sclerosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis [Phase 2]
A Phase 2 clinical trial evaluating IPX056 for spasticity in subjects with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Impact of Ketone Bodies and Epigallocatechin Gallate in Multiple Sclerosis [Phase 2]
Phase 2 trial investigating ketone bodies and epigallocatechin gallate in multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Telephone-Delivered Exercise for Multiple Sclerosis Fatigue [NA]
Completed clinical trial evaluating telephone-delivered exercise to alleviate fatigue in multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: Trial of Memantine for Cognitive Impairment in Multiple Sclerosis [Phase 2, Phase 3]
A completed clinical trial evaluating memantine for cognitive impairment in multiple sclerosis (Phase 2/3).
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Safety and Tolerability of Quetiapine in Multiple Sclerosis [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and tolerability of quetiapine in patients with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-30Clinical Trial Update: Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking and Quality of Life in MS [NA]
A completed clinical trial compared functional electrical stimulation cycling to cycling alone for walking and quality of life in people wit…
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START) [Phase 4]
Phase 4 trial evaluating telemetric ECG systems for first dose administration of fingolimod in multiple sclerosis; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: Comparison of the Efficacy and Mechanisms for MBCT and CT for Multiple Sclerosis (MS) Chronic Pain [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating MBCT vs CT for chronic pain in Multiple Sclerosis, examining efficacy and mechanisms.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Efficacy and Safety of 4-aminopyridine on Cognitive Performance and Motor Function of Patients With Multiple Sclerosis [Phase 2]
Phase 2 trial update evaluating 4-aminopyridine for cognitive performance and motor function in multiple sclerosis patients; study completed…
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: A Pilot Study of Lithium in Progressive Multiple Sclerosis [Phase 1, Phase 2]
Pilot study combining Phase 1/2 evaluating lithium in progressive multiple sclerosis; completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Transcranial Magnetic Stimulation (TMS) in Multiple Sclerosis [Phase 1, Phase 2]
Clinical trial update on transcranial magnetic stimulation (TMS) for multiple sclerosis covering Phase 1 and Phase 2, with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-08-15Clinical Trial Update: Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects [Phase 4]
A Phase 4 trial evaluating whether prednisone can reduce side effects of pegylated interferon beta-1a in multiple sclerosis patients.
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis [Phase 2]
Phase 2 clinical trial evaluating autologous mesenchymal bone marrow stem cells in active and progressive multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Isokinetic Exercises in Patients With Multiple Sclerosis [NA]
Clinical trial on isokinetic exercises for patients with Multiple Sclerosis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Integrating Caregiver Support Into MS Care [NA]
A completed clinical trial evaluating integrating caregiver support into multiple sclerosis care; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-12Clinical Trial Update: Towards Personalized Dosing of Natalizumab in Multiple Sclerosis [Phase 4]
A Phase 4 clinical trial update exploring personalized dosing of natalizumab for multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-28Clinical Trial Update: Exploring the Use of Non-invasive Neuromodulation Combined With Exercise in People With Advanced Multiple Sclerosis (MS) [NA]
Completed clinical trial investigating non-invasive neuromodulation combined with exercise for people with advanced multiple sclerosis; resu…
-
CLINICAL_TRIALS trial_result · 2019-06-27Clinical Trial Update: Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS). [Phase 3]
Phase 3 trial update assessing BG00012 effects on lymphocyte subsets and immunoglobulins in relapsing-remitting multiple sclerosis; study co…
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Wearable Lower Extremity Exoskeleton to Promote Walking in Persons With Multiple Sclerosis [NA]
A completed clinical trial investigating a wearable lower-extremity exoskeleton to promote walking in persons with multiple sclerosis, with …
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies [Phase 4]
Long-term follow-up results from the BENEFIT program in multiple sclerosis have completed phase 4 assessments.